All posts by imreal

ValvTechnologies, Inc. Names David Birks Regional Sales Director, Middle East and Africa


News Image

David Birks

ValvTechnologies, Inc., the global leader in the design and manufacturing of zero-leakage severe service isolation valve solutions is pleased to announce the appointment of David Birks as Regional Sales Director for the Middle East and Africa. Birks is responsible for leading ValvTechnologies’ business growth in these important strategic regions. He will be based in Dubai, United Arab Emirates.

With more than 20 years’ experience in the valve manufacturing industry, Birks brings extensive international sales and business management experience to ValvTechnologies. Most recently, he served as Vice President of Sales Project Pursuit for Emerson Valves, based in Dubai. Prior to that, Birks was the Vice President, Fisher Isolation Valves at Emerson Fisher. Birks has also previously held management positions at Tyco Valves and Controls, Saudi Electric Supply Company and Keystone Group.

“David has a proven track-record for uniting global teams to work together effectively,” said President Kevin Hunt. “Pair this with his depth of industry and regional knowledge, he is an exciting addition to our global executive team. I am confident that ValvTechnologies will be able to significantly extend its presence in the Middle East and Africa under David’s leadership.”

Birks holds a certificate in Mechanical Engineering and Fluid Dynamics from Sydney Technical College in Australia.

About ValvTechnologies

Founded in 1987 and headquartered in Houston, Texas, ValvTechnologies is the leading manufacturer of zero-leakage, high-performance isolation valve solutions providing an unsurpassed level of severe service isolation services and reliability to customers in the fossil power, nuclear generation, upstream oil and gas, downstream and chemical processing, mining and minerals, pulp and paper and other specialized industries.

Employing more than 400 people worldwide, ValvTechnologies has offices in Australia, Bangladesh, Belgium, Brazil, Canada, Chile, China, Colombia, India, Ireland, Japan, Kazakhstan, South Korea, Malaysia, Poland, Saudi Arabia, Singapore, Spain, Sri Lanka, Thailand, Turkey, United Arab Emirates, United Kingdom and United States.

In addition, ValvTechnologies partners with stocking distributors, independent representatives and authorized repair centers to service customers around the world.

To find out more about the products and services offered or to locate a representative, visit our website at http://www.valv.com. Connect with ValvTechnologies on YouTube, Instagram, Twitter, LinkedIn and Facebook.

Share article on social media or email:

Keller Grover LLP Investigating Tandem Diabetes Care


“Medical information is considered to be among the most personal and private of information under California law,” says Keller Grover LLP attorney Eric A. Grover. “For that reason, healthcare providers are required to give patients timely notice of data breaches and the negligent release and disclosure of medical information can, under certain circumstances, give rise to claims by affected individuals for money damages.”

Similar medical data breaches involving the failure to properly secure medical information have given rise to class action lawsuits. Recently, for example, St. Joseph Health Systems finalized a class action lawsuit settlement valued at over $30 million involving St. Joseph’s alleged failure to properly secure its network, allowing patient information to become publicly accessible on the internet.

If you have any information about the Tandem Diabetes Care data breach or are a California resident that has been affected by the data breach and have questions, contact Keller Grover’s attorneys at 888-535-5291 or by email at info@kellergrover.com.

Keller Grover LLP is a leader in the field of medical information privacy litigation and has represented clients in numerous medical data breach class action cases, including lawsuits against St. Joseph Health Systems, Stanford Hospitals and Clinics, Health Net and 21st Century Oncology. Keller Grover will not charge you for reviewing your information and all information that you provide to Keller Grover in the process of seeking legal advice will be held strictly confidential. (Attorney Advertising)

Share article on social media or email:

PTS Diagnostics and MedPro Healthcare Sales Solutions Enter Into Partnership


MedPro’s support is crucial to achieving our core mission of closing gaps in care and potentially improving the outcomes of individuals with chronic conditions such as diabetes and cardiovascular disease.

PTS Diagnostics, a U.S.-based manufacturer of point-of-care medical testing devices announced today that they are partnering with MedPro Healthcare Sales Solutions, a leading healthcare contract sales organization.

The partnership adds positions to the existing PTS Diagnostics sales force. These new representatives will be strategically staggered throughout the country and managed by PTS Diagnostics directors and senior sales managers. Together they’ll be responsible for expanding the footprint of the CardioChek® and A1CNow® product lines.

“MedPro’s support is crucial to achieving our core mission of closing gaps in care and potentially improving the outcomes of individuals with chronic conditions such as diabetes and cardiovascular disease,” said Cliffe Allen, VP of U.S. Sales of PTS Diagnostics. “Their knowledge regarding point-of-care testing combined with exceptional distribution relationships positions us for ongoing success in numerous vertical markets.”

MedPro was founded in 2006 and has grown into a leading sales force that’s trusted by manufacturers and distributors of all sizes. Their team’s connections span across a wide spectrum of healthcare delivery models, allowing for a streamlined sales cycle.

PTS Diagnostics’ solutions represent the first and only point-of-care lipid, glucose, and HbA1c tests sold by MedPro representatives.

“We’re thrilled to partner with PTS Diagnostics and believe that the certified accuracy, precision, and speed of their solutions will be a value add for physician offices, pharmacies, walk-in clinics, and more,” said Manny Losada, President of MedPro Healthcare Sales Solutions. Together we hope to positively impact at-risk populations at the point of care.

This announcement comes on the heels of PTS Diagnostics’ recent A1CNow+ ControlsTM product launch and it precedes future 2020 product announcements.

To learn more about PTS Diagnostics or to connect with a sales representative, email: customerservice@ptsdiagnostics.com, or call 877-870-5610.

About PTS Diagnostics

Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, we have helped medical professionals and patients achieve better health outcomes through our accurate, precise, fast, affordable, and certified point-of-care medical devices. Healthcare professionals have used our CardioChek® products to assess cardiovascular disease risks for millions of patients worldwide through lipid panel screening. And, our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. For more information, visit ptsdiagnostics.com.

About MedPro Healthcare Sales Solutions

Med-Pro Associates is a nationwide independent rep group specializing in representing leading manufacturers across the country who sell their products both through distribution and direct to the hospital, long term care, physician, dental and veterinary markets.

Share article on social media or email:

Kane Russell Coleman Logan CARES Task Force Will Provide Legal Guidance to Employers and Businesses to Navigate New Federal Aid for Businesses


News Image

Many of our attorneys across the firm have been working long hours to ensure our clients have the most up-to-date information during the coronavirus crisis. I am confident that the work product and the advice of our lawyers will be a useful resource for our clients at this very difficult time.

Immediately after President Trump signed the Coronavirus Aid, Relief and Economic Security (CARES) Act, Kane Russell Coleman Logan has announced its formation of the KRCL CARES Task Force. The initial team consists of six transactional lawyers and four litigators in Dallas and Houston: Gordon Russell, Arthur Nathan, Doug Bracken, Andrea “AJ” Johnson, Richard Hathaway, Demetri Economou, Drew Robertson, Emily Green, Kathleen Thompson and Jade Peterkin.

The task force will work with businesses and employers on the best processes for obtaining federal government relief aid and managing employees and payroll. The KRCL team has been developing the materials, ideas and advice needed to assist during the COVID-19 pandemic.

The CARES Act impacts unemployment insurance, business loans, employer-sponsored health insurance, retirement savings and employer-provided education assistance, as well as banking, real estate and equipment leasing, and the restaurant and insurance industries.

“The KRCL employment law group has been staying on top of COVID-19 developments as they change rapidly,” Employment Law Co-Chair Andrea “AJ” Johnson said. “We have written several essential articles for our Law in the Workplace blog and we are studying this new Act closely. Our goal is to assist clients with their most critical decisions as quickly as possible.”

“I am proud of the employment practice group for taking fast action,” said Gordon Russell, a founding Director of the firm. “Many of our attorneys across the firm have been working long hours to ensure our clients have the most up-to-date information during the coronavirus crisis. I am confident that the work product and the advice of our lawyers will be a useful resource for our clients at this very difficult time for all of us.”

Kane Russell Coleman Logan is a full-service law firm with offices in Dallas and Houston. Formed in 1992, the Firm provides professional services for clients ranging from Fortune 500 companies to medium-sized public and private companies to entrepreneurs. KRCL handles transactional, litigation and bankruptcy matters in Texas and throughout the country.

SOURCE: Kane Russell Coleman Logan PC

Follow Kane Russell Coleman Logan on LinkedIn

Follow Kane Russell Coleman Logan on Twitter

Like Kane Russell Coleman Logan on Facebook

Share article on social media or email:



Darin Lyon appointed as Chief Executive Officer for Anderson & Vreeland


Howard Vreeland, Chairman, Darin Lyon, President & CEO, Joe Anderson, Vice President

Howard Vreeland, Chairman, Darin Lyon, President & CEO, Joe Anderson, Vice President

Darin Lyon has led by example for 25 years. This is a very earned moment for him and the entire Anderson & Vreeland family. I am excited to watch Darin continue to cement our status in North America.

Darin Lyon has been appointed Chief Executive Officer of Anderson & Vreeland, the industry-leading manufacturer and distributor of flexographic printing technology and supplies. Formerly President, Mr. Lyon has held various executive roles at the company since 2003. In this expanded role, Mr. Lyon will hold the title of President & CEO.

With this appointment, Darin will be expanding his leadership role to focus on core initiatives that will further build on the foundation that has positioned Anderson & Vreeland as the market leader in the Flexographic printing and packing industry.

This new position will allow Darin to focus more on his passion for employee growth & engagement within the organization to develop depth in leadership that align with the core mission of the organization.

“Darin Lyon has led by example for 25 years,” says Chairman Howard Vreeland. “This is a very earned moment for him and the entire Anderson & Vreeland family. I am excited to watch Darin continue to cement our status as the leading flexographic and packaging printing technology provider in North America.,” said Howard Vreeland, Chairman of Anderson & Vreeland Inc.

“I am humbled and honored to have been appointed Chief Executive Officer of Anderson & Vreeland. For more than 25 years, I have viewed it as a privilege to be part of an organization who delivers high-quality services and innovative solutions to our valued clients, said Mr. Lyon. We continuously strive to develop the most talented professionals into leaders and do our part to invest in philanthropic efforts surrounding the education of our industry, Flexographic Printing & Packaging. We are an organization who will always reflect authentic, purposeful leadership which will be inclusive of all in an environment where our employees and customers’ voices are heard.”

Please join the Anderson & Vreeland Inc. team in congratulating Darin’s appointment to this new position.

About Anderson & Vreeland, Inc.

Anderson & Vreeland provides flexographic printers with innovative solutions that are tailored to their specific application. We do this by identifying the most effective & advanced technologies in our portfolio, educating our customers on how these products will improve their bottom line, and seamlessly integrate these solutions into our client’s business. We are a privately held company with over 55 years’ experience providing unrivaled customer service to the flexographic printing industry.

Further information is available on the web at http://www.AndersonVreeland.com.

Share article on social media or email:

Dr. Michele S. Green Continues Partnership with the Exclusive Haute Beauty Network


Dr. Michele Green has published numerous papers on the surgical reconstruction margins and treatment of malignant melanoma that highlight her expertise in this field. Dr. Green is also a principal member of the Skin Cancer Foundation and volunteers her time at skin cancer screenings.

Dr. Michele S. Green, board-certified Anti-Aging Expert representing the New York market, is continuing her partnership with the esteemed Haute Beauty network.

The Haute Beauty Network, well known for its exclusivity, and luxurious lifestyle, is privileged to present Dr. Green as a leading Anti-Aging Expert.

Haute Beauty offers a prominent collective of leading doctors nationwide. The invitation-only exclusive network maintains elite as ever, with only two doctors in every market. This partnership allows Haute Beauty to connect its affluent readers with industry-leading doctors.

Visit Dr. Green’s Haute Beauty Profile: https://hauteliving.com/hautebeauty/member/dr-michele-s-green/

About Dr. Green:

Dr. Michele S. Green is a board-certified dermatologist. Upper East Side patients and those from the surrounding areas of New York City flock to her practice for a variety of cosmetic dermatology treatments. A graduate from Yale University, with an MD from Mount Sinai Medical School in NYC, Dr. Green treats some of the most discerning, demanding women and men in the world, with issues ranging from premature skin aging to hyperpigmentation, rosacea, acne, and skin cancer.

Her most popular cosmetic dermatology treatments include:

Thermage® – Tightens skin without surgery

Fraxel Dual®– An excellent option for reducing the appearance of fine lines, rough skin texture, and other blemishes

CoolSculpting® – A leading body contouring treatment that can reduce inches on your thighs, waist and other areas of the body

A True Patient Focus

Dr. Green respects the healing process and believes in the value of spending as much time as needed with her patients, addressing questions, and reviewing all available options for treatment and products. She takes a conservative yet proven approach, with the goal of helping you feel more confident and optimistic about your appearance.

In addition to being a keen diagnostician and board-certified dermatologist, Dr. Green also possesses an exceptional technical ability. She skillfully performs the latest in laser therapies, chemical peels, and other skin rejuvenation techniques. Learn why being board certified in dermatology matters.

Earlier in her career, Dr. Green worked for global skin care brands, L’Oreal, Johnson and Johnson, Bioré® and RoC® on the research, development, and safety testing of worldwide product launches. She has been tapped by magazine editors for expert skincare advice, product recommendations for articles, and trend stories. She has appeared on TV news segments to offer her expertise. Additionally, Dr. Green has published articles on topics ranging from skin cancer to dermal fillers in professional journals including The Journal of American Academy of Dermatology and Cosmetic Dermatology.

With the access to cutting-edge research and ingredients from around the world, coupled with her knowledge about what woman want, she formulated her own specialty line of products called MGSKINLABS, Inc. “If I’m going to recommend a product, I really have to believe in it,” Dr. Green states. “With countless brands all making similar claims, women are confused, and using the wrong product can be worse than using no products at all.”

With patient feedback at the cornerstone of product development, MGSKINLABS combines the most synergistic blends of clinically proven ingredients and sophisticated technologies. MGSKINLABS products address a variety of skincare challenges caused by environmental assaults and genetics. Thanks to visibly remarkable results and rave reviews, MGSKINLABS enables Dr. Green to extend her extraordinary treatment approach toward skincare beyond her NYC practice.

Dr. Michele Green has published numerous papers on the surgical reconstruction margins and treatment of malignant melanoma that highlight her expertise in this field. Dr. Green is also a principal member of the Skin Cancer Foundation and volunteers her time at skin cancer screenings.

Share article on social media or email:

Velocidy Bio starts distributing NEXTGENPCR, an instrument capable of analyzing 22,860 SARS-CoV-2 coronavirus tests in 24 hours


“Velocidy Bio has always believed that decreasing time-to-result represents an unmet need in the life sciences space.” – Brian McNally, CEO, Velocidy Bio

Velocidy Bio’s Dutch biotech partner, Molecular Biology Systems (MBS), has developed a new method using its revolutionary NEXTGENPCR that decreases the testing time for SARS-CoV-2 to eight minutes, compared to current systems that take over an hour. Utilizing this method, a single unit the size of a shoebox could perform a hundred and eighty (180) amplification runs a day, an almost ten-fold increase over the current US Centers for Disease Control (CDC) recommended instrumentation. According to Gert de Vos, MBS CEO, this protocol produces a simple yes/no answer and a single instrument is capable of running 24/7, analyzing 22,860 samples per day.

NEXTGENPCR machines launched about two years ago and Velocidy Bio is the exclusive distributor for the USA and Canada. According to Brian McNally, the CEO of Velocidy Bio, a single unit could potentially test every employee at Frederick Memorial Health every day in about 3 hours. McNally added, “Velocidy Bio has always believed that decreasing time-to-result represents an unmet need in the life sciences space. We have committed ourselves to finding solutions either through internal projects or external partnerships that accelerate lab work. We have been in close collaboration with MBS and look forward to supporting the US and Canadian labs that are interested in this solution.”

Velocidy Bio is currently a member of Frederick Innovative Technology Center, Inc. (FITCI), a technology incubator and accelerator that provides start-up companies with business support and mentorship. “As a young business, we wouldn’t have had the resources to navigate all of the complexities of this crisis without FITCI and would not have been prepared to support the US and Canadian labs with the NEXTGENPCR technology”, added McNally.

NEXTGENPCR instruments are available to order today. Please follow the link to learn more – https://www.velocidybio.com/

About Velocidy Bio, Inc.

Velocidy Bio is focused on delivering solutions that decrease time-to-results for biological laboratories. Working together with innovative organizations, Velocidy Bio offers solutions globally that reduce protocols from hours to minutes. These accelerated protocols enable scientists to increase their productivity and reduce stress associated with delays in generating results. Initially, Velocidy Bio is focused on reducing the time required to extract, amplify and analyze nucleic acids. Further information can be found at http://www.velocidybio.com.

About Molecular Biology Systems

Molecular Biology Systems B.V. is a Netherlands company that developed and commercialized NEXTGENPCR, a universal ultrafast PCR system. The NEXTENPCR instrument uses an innovative temperature control method during cycling, which eliminates ramp time. Molecular Biology Systems offers their NEXTGENPCR instrument, accessories and consumables around the world, to laboratories in life science research, pharmaceutical and biotechnology companies, forensics, veterinary testing and food safety. Further information can be found at http://www.nextgenpcr.com.

Share article on social media or email:

Domestic Gag Rule Reduces Contraceptive Access For Nearly 200,000 Women Living In Minnesota


“Even before the domestic gag rule was implemented, almost 300,000 low-income women in Minnesota lived in contraceptive deserts, counties without reasonable access to the full range of contraceptive methods,” said Ginny Ehrlich, CEO, Power to Decide.

According to data released by Power to Decide, an estimated 193,110 Minnesota women of reproductive age (13-44) in need of publicly funded contraception live in counties impacted by the implementation of the Title X Family Planning Program “domestic gag rule.” Nearly one-quarter of Minnesota’s counties have lost some or all of their Title X resources.

The domestic gag rule requires health providers receiving Title X funds to withhold information from patients about abortion services and care. In addition, health centers are required to cease providing abortion care with non-Title X funds at sites that offer Title X supported services, such as contraceptive care, breast and cervical cancer screening and STI testing. The rule requires that abortion services, no matter how they are funded, be performed at a separate physical site, which is impossible for many health centers.

“The implementation of the domestic gag rule could impact nearly 200,000 women in need in Minnesota,” said Ginny Ehrlich, CEO, Power to Decide. “This federal rule exacerbates an already challenging contraceptive access landscape for women struggling to make ends meet. Even before the domestic gag rule was implemented, almost 300,000 low-income women in Minnesota lived in contraceptive deserts, counties without reasonable access to the full range of contraceptive methods. As a result, these women face untenable financial barriers such as transportation, child care and taking unpaid time from work costs incurred just to get the contraception they need.”

Data from Power to Decide show that 283,400 women living at or below 250% of the poverty level in Minnesota live in contraceptive deserts, counties in which there is not reasonable access to a health center offering the full range of contraceptive methods. Nationally, more than 19 million U.S. women of low income live in contraceptive deserts.

In this challenging landscape, states like Minnesota can take steps to partially alleviate the impact of damaging federal policies and to proactively expand access to contraception in various ways. These policies include allowing pharmacists to prescribe contraception, requiring insurance to cover an extended supply of prescription contraceptives and enacting policies that protect insurance coverage of the full range of contraceptive methods. Minnesota has expanded Medicaid to low-income adults, which helps decrease the percentage of uninsured women, and by extension, give them the contraceptive coverage they need to live healthy lives. To further expand access, Minnesota is currently considering legislation that would allow pharmacists to prescribe contraception. More information about these policies can be found here.

Power to Decide is a private, non-partisan, non-profit organization that works to ensure all people—no matter who they are, where they live or what their economic status might be—have the power to decide if, when and under what circumstances to get pregnant and have a child. Please visit us at http://www.PowerToDecide.org or follow us on Facebook and Twitter.

Share article on social media or email:

Spanish Speaking Employees Have Resources During COVID-19 Crisis


In this time of rapidly changing situations and information, Arrow Benefits Group (ABG) wants to make sure language is not an added barrier or reason employees don’t receive vital information, messages and council. This is a critical and sensitive time for businesses and employees alike. In a commitment to their community, ABG will extend complimentary services from Alianza, its Spanish Language Division, which consists of a team of bilingual and bicultural specialists and makes available for Spanish speaking employees access for help via email, text, video chat and a dedicated phone line. Benefits translation is an intricate process and translation services are not always reliable, in fact, too often the interpretation can fail to communicate the true meaning intended. ABG does not charge for this service for clients and at this time has extended the service to any interested employer or employee who has the need for translation of benefits while the COVID-19 crisis continues. “Our commitment to the community goes beyond what we do for clients – it’s about people and their security and safety,” says Alianza team lead Rosario Avila. She can be contacted directly for consult at (707) 992-3795 – email: rosarioa@arrowbenefitsgroup.com.

Alianza will Translate:

  • Notices and documents pertaining to COVID-19
  • Employment notices and letters
  • Notices and letters regarding employee benefits (including COBRA, FSA, etc.)

ABG is available for personalized phone conversations or virtual group meetings, video chats, and recordings. Right now, benefits information is rapidly changing. Written translations aren’t enough, and do not lessen the confusion. The team will speak directly with employees in Spanish to help them understand the message you need to send and convey.

About Alianza – Spanish Language Division:

Communicating your employee benefits program in one’s own native language while being culturally sensitive is essential for employee morale and adds significant value to your employee benefits program. Alianza breaks down the complexity of insurance by eliminating the language barrier. Our Spanish Language Division was specifically designed to educate, answer questions, and give guidance and resources regarding not only health insurance but employer benefits as well. Employees and their families can call, email and text their questions and concerns. They will receive a direct response from a fluent, native Spanish speaking benefit specialist offering one-on-one guidance and support. We understand that translation alone is NOT always enough to serve your audience, especially when dealing with the most important aspect of insurance – one’s own health.

About Arrow Benefits Group

Arrow Benefits Group, the third largest benefits firm in the North Bay, is a proud member of TRUE Network Advisors. Arrow Benefits Group is the single-source solution for managing the complexities of benefits with expert advice, customized programs, and personalized solutions. Arrow’s innovative programs control costs and give employees a greater sense of financial and emotional security. For straight answers to employee benefits call 707-992-3780 or visit http://www.arrowbenefitsgroup.com.

For latest updates and news on COVID-19, see our dedicated portal at http://www.arrowbenefitsgroup.com and follow us at:

https://www.facebook.com/ArrowBenefitsGroup

https://www.linkedin.com/company/arrow-benefits-group/

https://twitter.com/ArrowBenefits

Share article on social media or email:



Berkshire Hathaway HomeServices Hodnett Cooper Real Estate receives Round Table Award and 4th Quarter award for 2019 performance


Berkshire Hathaway HomeServices Hodnett Cooper Real Estate today announced its Brunswick office location is the recipient of the prestigious Berkshire Hathaway HomeServices Round Table Award for residential units in 2019 for the US South Region. In addition, the Brunswick office location was recognized for outstanding 4th quarter performance, placing first in the number of residential units sold in the region.

The Round Table Award honors the top three network member offices from each U.S. region, ranked among offices of similar size. Hodnett Cooper Real Estate was recognized during a special ceremony at Berkshire Hathaway HomeServices’ annual Sales Convention in Nashville earlier this month, where Missy Neu, Vice President of Development, accepted the award for the Brunswick office location.

“We are thrilled to have earned our spot as one of the top-producing network offices within our region. Our team works hard and are so committed to their clients. The credit for this achievement belongs to those dedicated agents in our Brunswick office location,” shared Pat Hodnett Cooper, owner and broker.

Berkshire Hathaway HomeServices Hodnett Cooper Real Estate, which is independently owned and operated, became a member of the Berkshire Hathaway HomeServices brokerage network, operated by HSF Affiliates LLC, in 2017. Since that time, the company and several of its Realtors have earned a host of honors and awards.

About Berkshire Hathaway HomeServices Hodnett Cooper Real Estate

Hodnett Cooper Real Estate is a family-owned and operated company with four offices throughout the Golden Isles offering a full range of real estate services including real estate sales, residential rentals, property management and commercial sales. The brokerage is the premier real estate company in southeast coastal Georgia with a professional and diverse team of agents. Visit http://www.BHHSHodnettCooper.com.

About Berkshire Hathaway HomeServices

Berkshire Hathaway HomeServices, based in Irvine, CA, is a brand-new real estate brokerage network built for a new era in residential real estate. The network, among the few organizations entrusted to use the world-renowned Berkshire Hathaway name, brings to the real estate market a definitive mark of trust, integrity, stability and longevity.

About HSF Affiliates LLC

Irvine, CA-based HSF Affiliates LLC operates Berkshire Hathaway HomeServices, Prudential Real Estate and Real Living Real Estate franchise networks. The company is a joint venture of which HomeServices of America, Inc., the nation’s second-largest, full-service residential brokerage firm, is a majority owner. HomeServices of America is an affiliate of world-renowned Berkshire Hathaway Inc.

Contact:

Catherine Maybank

(912) 638-5450

catherine@hcrega.com

Share article on social media or email: